Related references
Note: Only part of the references are listed.Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid β-lactamase display
D. Bannister et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Expression of antibody variable region-human alkaline phosphatase fusion proteins in mammalian cells
Yoshiyuki Sasajima et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Aprotease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
John E. Weldon et al.
BLOOD (2009)
Approach to the patient after relapse of hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA & LYMPHOMA (2009)
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins
Xing Du et al.
BLOOD (2008)
Phase I study of SS1P a recombinant anti-mesothelin immunotoxin given as a bolus IV infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2007)
Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy
Qi Zhang et al.
CELL RESEARCH (2007)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-Cell malignancies
RJ Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin
M Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Monoclonal antibody successes in the clinic
JM Reichert et al.
NATURE BIOTECHNOLOGY (2005)
Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
J Krauss et al.
PROTEIN ENGINEERING (2003)
VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates
N Hugo et al.
PROTEIN ENGINEERING (2003)
Antibody multispecificity mediated by conformational diversity
LC James et al.
SCIENCE (2003)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
IMGT, the international ImMunoGeneTics database
MP Lefranc
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
